Skip to main content

Animations

MJFF Publications

5931 - 5940 of 6431 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2025
  • 2023
  • 2023
  • 2023
  • 2025
  • 2019
  • 2018
  • 2015
  • Summary Details
    OPEN
    Title: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-85293-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET study
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100353
    Citation Count: 1
  • Summary Details
    OPEN
    Title: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms242216445
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103085
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
    Journal Name: Brain, Behavior, & Immunity - Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbih.2023.100656
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Hemispheric lateralization of dopamine transporter binding in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.02.015
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Alpha galactosidase A activity in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.012
    Citation Count: 73
  • Summary Details
    OPEN
    Title: A Novel Lead Design for Modulation and Sensing of Deep Brain Structures
    Journal Name: IEEE Transactions on Biomedical Engineering
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.